Analysis

Which GLP-1 telehealth providers serve my state?

How to verify a provider's state and product availability, use state directories, and distinguish online coverage from guaranteed prescribing or delivery.

Claims are checked against the sources cited in this article. Nothing here is individualized medical advice. How we research

On this page

As checked October 9, 2026, providers with broad state coverage include Ro, reporting company-level service in all 50 states and DC with treatments varying by location, and Gentle Health, reporting 40 states plus DC. Our state provider guides list reviewed choices for each state; confirm the exact GLP-1 service where you will receive care, because a company’s overall coverage footprint is not a guarantee for every medication or prescription.

Start with the state where you will receive care

Telehealth happens online, but location still matters. HHS explains that cross-state practice depends on state rules and advises providers to verify patient location before an appointment. Its interstate licensing guide describes several permitted pathways rather than one universal national license.

When asking a service about availability, state where you will physically be during the appointment, not only the address attached to your account. If you are traveling, tell the service before booking. A company’s ability to serve your home state does not independently establish that it can deliver the same service while you are elsewhere.

This is an administrative availability guide. It does not decide whether a particular treatment is appropriate or determine the legal status of a specific prescription. Those decisions require the relevant care team and applicable rules.

Company coverage and medication coverage are separate

A provider may operate nationally while a particular program, product or pharmacy route has narrower availability. Read the qualification beside the state count. “All 50 states” can describe the company without establishing that every medicine it advertises is available in all 50.

The useful question is precise: “Do you currently offer this named product and service to someone physically located in this state, and what process is required?” Ask about the product’s form as well. A statement about semaglutide broadly does not necessarily confirm a branded pen, a tablet or a particular compounded product.

Company service, product offering, appointment access and pharmacy fulfillment are different checks. A state listing can establish that the company advertises a service there without proving stock, a clinician’s decision or delivery for an individual order.

Three examples of how to read the evidence

Provider example What its source establishes What remains to confirm
Gentle Health Company reports 40 states plus DC; identifies James Simmons, MD, as its physician and lists states Current intake eligibility, actual prescription decision and pharmacy fulfillment
Ro Reports company services in all 50 states plus DC, while saying programs and treatments vary by location The exact requested GLP-1 program in your state
Mochi Health in Arizona Its Arizona page names compounded semaglutide and tirzepatide among product options Current account-specific offering, pharmacy, price and individual prescribing decision

Sources checked October 9: Gentle Health’s coverage account, Ro’s location answer, and Mochi’s Arizona page. These examples illustrate source scope; they are not a claim that this is every available provider or that the services are interchangeable.

Our Gentle Health profile, Ro profile and Mochi profile provide service and payment context. A physician’s name or company footprint is not a guarantee that every applicant receives medication.

How to use Inside Telehealth’s state directories

Start with Locations and choose the relevant state. For a specific service, use the weight-care directory. For a product-focused starting point, use our semaglutide guide or tirzepatide guide.

The provider links are discovery tools. Follow through to the profile and official source before paying. Check the factual observation date and any availability qualification, then request confirmation from the provider if the information is ambiguous or your situation differs from the general listing.

A city guide should not be interpreted as proof of a local clinic or prescriber office. For statewide online care, a city page can organize providers serving the surrounding state. It does not establish an in-person practice at that address or a city-specific medication supply.

If a directory does not show an offer, that absence alone is not proof that no service exists. Public evidence may be incomplete or the offering may not have been verified. Ask the company directly rather than turning a missing listing into a categorical denial.

Questions to ask before enrollment

Give the provider a clear description of the administrative request and ask for a written answer:

  • Do you currently accept patients physically located in this state for the named program?
  • Is the exact medication form offered there, subject to clinician review?
  • Is a live visit required by your process, and can you currently arrange one?
  • Which pharmacy handles fulfillment, and can it dispense to this state?
  • What fees are collected before a prescription decision?
  • What happens to those fees if the service cannot proceed?

These questions do not ask customer support to prescribe or interpret clinical suitability. They establish whether the advertised service and payment process fit the location and request.

Keep the reply with the quote. A generic chat answer about national coverage is less useful than confirmation identifying the specific program and state. If the answer concerns only the company, ask the product question again rather than assuming it was answered.

Availability is also different from insurance coverage

A provider can serve your state while operating on a cash-pay basis, or offer care there while a separate pharmacy claim depends on insurance. Ask who bills the appointment, membership and medicine. State access does not show that your plan pays for any of them.

Our compounded GLP-1 price overview separates required payments and commitments for reviewed offers. It is not a state licensing determination or proof of insurer participation. Use availability evidence and price evidence side by side instead of treating one as a substitute for the other.

The strongest practical answer combines a current state source, a product-specific statement and confirmation of the actual care and pharmacy process. Keep each qualification intact: an online footprint helps find a service, but does not promise a prescription, appointment or shipment.